Biocon hits record high on strong Q2 earnings
Business Standard India / Posted yesterday
3 related stories
for review by EMA was a critical milestone this quarter. This is our second filing in EU. The tentative USFDA approval for Rosuvastatin calcium tablets heralds our entry into the US generics market,” Kiran Mazumdar-Shaw said.
At 10:02 am, the... Read more